University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Targeting the HOX/PBX dimer in breast cancer

Morgan, Richard, Boxall, A, Simpson, Guy, Michael, Agnieszka, Pandha, Hardev, Harrington, KJ and Gillett, C (2012) Targeting the HOX/PBX dimer in breast cancer Breast Cancer Research and Treatment, 136 (2). pp. 389-398.

HOX breast cancer BCR 171212.pdf

Download (245kB)
[img] Slideshow

Download (249kB)
[img] Slideshow

Download (620kB)
[img] Slideshow

Download (1MB)
[img] Slideshow (deleted)
Restricted to Repository staff only

Download (36kB)
[img] Slideshow
Supplementary Fig 2.ppt

Download (114kB)
[img] Slideshow
Supplementary Fig3.ppt

Download (212kB)


The HOX genes are a family of closely related transcription factors that help to define the identity of cells and tissues during embryonic development and which are also frequently deregulated in a number of malignancies, including breast cancer. While relatively little is known about the roles that individual HOX genes play in cancer, it is however clear that these roles can be both contradictory, with some members acting as oncogenes and some as tumor suppressors, and also redundant, with several genes essentially having the same function. Here, we have attempted to address this complexity using the HXR9 peptide to target the interaction between HOX proteins and PBX, a second transcription factor that serves as a common co-factor for many HOX proteins. We show that HXR9 causes apoptosis in a number of breast cancer-derived cell lines and that sensitivity to HXR9 is directly related to the averaged expression of HOX genes HOXB1 through to HOXB9, providing a potential biomarker to predict the sensitivity of breast tumors to HXR9 or its derivatives. Measuring the expression of HOX genes HOXB1-HOXB9 in primary tumors revealed that a subset of tumors show highly elevated expression indicating that these might be potentially very sensitive to killing by HXR9. Furthermore, we show that while HXR9 blocks the oncogenic activity of HOX genes, it does not affect the known tumor-suppressor properties of a subset of HOX genes in breast cancer.

Item Type: Article
Divisions : Faculty of Health and Medical Sciences > School of Biosciences and Medicine
Authors :
Boxall, A
Harrington, KJ
Gillett, C
Date : November 2012
DOI : 10.1007/s10549-012-2259-2
Copyright Disclaimer : © Springer Science+Business Media New York 2012
Uncontrolled Keywords : Breast cancer; SKBR3; MCF7; HXR9; HOX; PBX
Depositing User : Symplectic Elements
Date Deposited : 18 Aug 2017 08:10
Last Modified : 06 Jul 2019 05:11

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800